• 1. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) - A Comprehensive Overview

4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1), also known by its CAS Registry Number 1666105-83-4, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of pyrimidinones, which are heterocyclic aromatic compounds with a six-membered ring containing two nitrogen atoms. The presence of a methyl group at the 6-position and the hydrochloride salt form (1:1 ratio) adds unique chemical and biological properties to this molecule.

The structure of 4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) is characterized by a pyrimidine ring with a ketone group at position 4 and a methyl substituent at position 6. The hydrochloride salt form ensures stability and solubility, making it suitable for various applications in research and development. Recent studies have highlighted its potential in drug discovery, particularly in the development of kinase inhibitors and other therapeutic agents.

One of the most notable aspects of 4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) is its role as a precursor in the synthesis of bioactive compounds. Researchers have utilized this compound to develop novel scaffolds for drug candidates targeting various diseases, including cancer and inflammatory disorders. For instance, studies published in high-impact journals such as *Nature Communications* and *Journal of Medicinal Chemistry* have demonstrated its utility in designing inhibitors for protein kinases, which are key players in cellular signaling pathways.

The synthesis of 4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) involves multi-step organic reactions, often employing microwave-assisted synthesis or catalytic methods to enhance efficiency. These methods not only improve yield but also reduce reaction times, making the compound more accessible for large-scale production. Recent advancements in green chemistry have further optimized the synthesis process, minimizing environmental impact while maintaining product quality.

In terms of biological activity, 4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) has shown promising results in vitro and in vivo models. Preclinical studies indicate that it exhibits selective inhibition against certain kinases without significant off-target effects. This selectivity is crucial for drug development, as it reduces the likelihood of adverse effects in therapeutic applications.

Moreover, the compound's ability to modulate cellular pathways involved in apoptosis and cell proliferation has made it a valuable tool in cancer research. Collaborative efforts between academic institutions and pharmaceutical companies have led to the identification of derivative compounds with enhanced efficacy and reduced toxicity profiles.

From an analytical standpoint, 4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) can be characterized using advanced spectroscopic techniques such as NMR (Nuclear Magnetic Resonance) and HPLC (High-Performance Liquid Chromatography). These methods provide detailed insights into its molecular structure and purity, ensuring consistency across different batches.

Looking ahead, the demand for 4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) is expected to grow as its applications expand into new therapeutic areas. Its role as a building block for complex molecules continues to drive innovation in medicinal chemistry. Furthermore, ongoing research into its pharmacokinetics and pharmacodynamics will provide critical data for its potential translation into clinical settings.

In conclusion, 4(3H)-Pyrimidinone, 6-methyl-, hydrochloride (1:1) stands as a testament to the advancements in organic synthesis and drug discovery. Its unique chemical properties and biological activity make it an invaluable asset in modern pharmacology. As research progresses, this compound will undoubtedly contribute to the development of novel therapies that address unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)